TRANSCRIPTOGEN LTD

Active Cambridge

Research and experimental development on biotechnology

0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
T

TRANSCRIPTOGEN LTD

Research and experimental development on biotechnology

Founded 25 Mar 2013 Active Cambridge, United Kingdom 0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 31 Mar 2026 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 7 Apr 2026 Next due 19 Apr 2027 11 months remaining
Net assets £96K £15K 2024 year on year
Total assets £111K £15K 2024 year on year
Total Liabilities £16K £80 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Unit 1, Cambridge House Camboro Business Park Oakington Road, Girton Cambridge Cambridgeshire CB3 0QH United Kingdom

Website

www.example.com

Full company profile for TRANSCRIPTOGEN LTD (08461104), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 25 Mar 2013. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2013–2024)

Cash in Bank

£97.45k

Decreased by £14.82k (-13%)

Net Assets

£95.88k

Decreased by £14.73k (-13%)

Total Liabilities

£15.57k

Decreased by £80.00 (-1%)

Turnover

N/A

Employees

N/A

Debt Ratio

14%

Increased by 2 (+17%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Apr 2016Seed

Share Capital

Share Capital

Share allotments and capital structure

9 Allotments 10,939 Shares £445.82m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
23 Dec 20201,668£81k£48.78
30 Jul 2020614£30k£48.78
1 Jul 2020406£20k£48.78
31 Mar 20201,451£71k£48.78
28 Feb 20201,382£67k£48.78

Officers

Officers

2 active 1 resigned
Status
Fox, John Stephen, DrDirectorBritishEngland711 Jan 2017Active
Thurston, David Edwin, ProfessorDirectorBritishUnited Kingdom7025 Mar 2013Active

Shareholders

Shareholders (9)

Kcp Nominees Ltd
46.2%
David Edwin Thurston
19.7%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Savvas Ioannou Neophytou

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB May 1972
Nature of Control
  • Significant Influence Or Control

Dr Savvas Ioannou Neophytou

Ceased 28 Feb 2020

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 Apr 2026Persons With Significant ControlCessation of Savvas Ioannou Neophytou as a person with significant control on 28 Feb 2020
29 Apr 2026Persons With Significant ControlNotification of a person with significant control statement
7 Apr 2026Confirmation StatementConfirmation statement made on 5 Apr 2026 with updates
31 Mar 2026AccountsAnnual accounts made up to 31 Dec 2025
8 Apr 2025Confirmation StatementConfirmation statement made on 5 Apr 2025 with updates
29 Apr 2026 Persons With Significant Control

Cessation of Savvas Ioannou Neophytou as a person with significant control on 28 Feb 2020

29 Apr 2026 Persons With Significant Control

Notification of a person with significant control statement

7 Apr 2026 Confirmation Statement

Confirmation statement made on 5 Apr 2026 with updates

31 Mar 2026 Accounts

Annual accounts made up to 31 Dec 2025

8 Apr 2025 Confirmation Statement

Confirmation statement made on 5 Apr 2025 with updates

Recent Activity

Latest Activity

Cessation of Savvas Ioannou Neophytou as a person with significant control on 28 Feb 2020

1 days ago on 29 Apr 2026

Notification of a person with significant control statement

1 days ago on 29 Apr 2026

Confirmation statement made on 5 Apr 2026 with updates

3 weeks ago on 7 Apr 2026

Annual accounts made up to 31 Dec 2025

1 months ago on 31 Mar 2026

Confirmation statement made on 5 Apr 2025 with updates

1 years ago on 8 Apr 2025